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From a survey undertaken by the European Society ofThoracic Surgeons, we know that pulmonary metastasec-
tomy is very common.1 It has become one of the largest
components of the thoracic surgical case volume in Europe,
Japan, and North America. In this historical summary, we do
not consider the question of effectiveness or the technical
aspects of the practice; other articles in this supplement to the
Journal of Thoracic Oncology, devoted to the work of the
European Society of Thoracic Surgeons Metastasectomy
Working Group,2 deal with those issues. Here, we describe
something of the context in which the practice has grown to
better understand how pulmonary metastasectomy has gained
its place in thoracic surgical practice.
It is traditional to introduce clinical reviews or reports
with a few historical references. Here are some of the more
often cited instances:
Y In 1927, Tudor Edwards performed a sublobar resec-
tion for a metastasis of sarcoma of the leg after
amputation 6 years earlier at the Royal Brompton
Hospital in London.3
Y In Boston in 1933, Churchill performed a lobectomy for
synchronous metastatic kidney cancer.4
Y In a 1944 “recent advances” lecture to the Massachusetts
Medical Society, Alfred Blalock related a recent expe-
rience of performing a right pneumonectomy for a
metastasis, 4 years after the resection of a large bowel
carcinoma.5
Throughout history, surgeons have used case examples
as an aid not only to teaching but also to make the case for
doing something different or innovative. However, the sur-
geons wrote up these cases in which pulmonary metastases
were removed precisely, because they were unrepresentative
of contemporary practice. None claimed to have introduced a
practice that they predicted or asked to be followed. Then,
why are they cited by so many recent authors? These most
cited examples were from thoracic surgeons who became
great names in 20th century surgery. There is a desire to add
authority to our own efforts by linking our work to such
famous names.6
More instructive might be to consider an example of the
adoption of pulmonary metastasectomy in osteosarcoma that
represents the paradigm of salvage surgery. In this disease,
metastasectomy had been used selectively for occasional use
in solitary relapses over many years. Memorial Hospital led
this experience based on the observation that 83% of osteo-
sarcoma patients treated by amputation developed lung me-
tastases within the first 2 years, and none of them was alive
at 5 years. There was a ready flow of patients with no other
hope. Because there were known to be some very long-term
survivors on the record, the practice grew to become rou-
tinely considered in patients with lung metastases, albeit
selectively applied. In 1971, Edward Beattie described his
strategy of systematic and iterative resection of lung metas-
tases, which introduced at Memorial Sloan-Kettering, with a
consecutive series of 29 patients. Long-term follow-up of this
historical series showed that four of the six 10-year survivors
lived more than 19 years after as many as nine thoracoto-
mies.7,8 The continuing presentation of young patients with
sarcoma and the absence of alternative effective treatments
has ensured a place for this surgery in contemporary thoracic
surgical practice.9
In this practice, the commonest malignancy for which
pulmonary metastasectomy is used is colorectal cancer, a
much more common cancer than osteosarcoma. The history
of its adoption had rather different driving forces. Lung
cancer practice is very familiar to thoracic surgeons; resection
is not usually performed if there is evidence of metastatic
disease because there is no chance of cure and, except in
specific circumstances, there is no palliative role for lung
resection under these circumstances. The situation in colo-
rectal cancer is very different: there are often compelling
grounds to resect the primary to relieve or preempt obstruc-
tion. In addition, other symptoms can be anticipated such as
fistula formation to the bladder and vagina, tenesmus, or the
terrible pain of sacral invasion. Resection of the primary
colorectal cancer is an effective means of improving the
patient’s life—even if the operating surgeon, working in the
abdomen, can see metastases there in the liver.
The notion arose that the portal venous drainage pro-
vided a “first filter” and thus a second chance of cure in that
the metastases might be trapped in the lung and dissemination
of the disease arrested for a time. At about the same time, but
more to address local occurrence, the concept of “second
look” surgery was being promulgated.10 Patients would be
screened for an increase in carcinoma embryonic antigen and
reinvestigated and operated.11
Liver resection was a considerable challenge to be
overcome; an operation early in this era has been described
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by a present senior academic in health service research who
was a surgical resident in the early days of liver resection,
which illustrates the obstacles that are overcome in the
pioneering of as yet unaccepted surgical ideas.12 In the event,
the “first filter” concept was abandoned. It turned out that
there was no difference in the relative rates of liver and lung
metastases,13 which largely refuted the first filter hypothesis,
but the practice of hepatic metastasectomy became estab-
lished nevertheless.14 Similar favorable results have been
reported after repeated liver, or liver and lung, salvage me-
tastasectomy for colorectal cancer. Pulmonary metastasec-
tomy that was being done in a few occasional cases gathered
considerable momentum from the acceptance that metasta-
sectomy was an appropriate response to recurrence in colo-
rectal cancer. Pulmonary metastasectomy has increased in
volume but has changed little case selection and outcome for
more than 40 years.15
There has been a conceptual change in the approach to
cancer. Cancer teams began to talk about managing cancer as
chronic disease. Part of the application of this expanded
concept of the role of surgery in cancer management is liver
and lung metastasectomy for colorectal cancer16,17 and lung
metastasectomy for cancer of a wide range of primary sites.
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